Justification for Thai phase III HIV vaccine trial

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1426, 2004-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase III HIV-1 vaccine trials require better rationale

By  

Inpharma, Vol. 1, Iss. 1423, 2004-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

GlaxoSmithKline (GSK) has discontinued enrolment into its phase III trial of the HIV entry inhibitor, aplaviroc [GW 873140]

By  

Reactions Weekly, Vol. 1, Iss. 1076, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

HIV vaccine fails to Step up in test-of-concept trial

By  

Inpharma, Vol. 1, Iss. 1665, 2008-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

NIAID decides not to go ahead with PAVE 100 HIV vaccine trial

By  

Inpharma, Vol. 1, Iss. 1648, 2008-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Phase III ATENA Trial of Exemestane Discontinued

By Sweetlove Mel  

Pharmaceutical Medicine, Vol. 26, Iss. 1, 2012-02 ,pp. : 45-47

Adis International

Access to resources Recommend Favorite